Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TYME - TYME Technologies: My Bamboo Speculation In A Potential Leader In Cancer Metabolism-Based Therapies.

TYME - TYME Technologies: My Bamboo Speculation In A Potential Leader In Cancer Metabolism-Based Therapies.

Tyme Technologies Inc.
  • I am taking a "Bamboo Investment" approach to Tyme Technologies in anticipation the company's pivotal trial data will confirm SM-88's ability to be a game changing oncology agent.
  • Tyme is matching SM-88 up against pancreatic cancer in the 2nd and 3rd lines of treatment. If approved, SM-88 will be the first FDA approved product for 3rd-line treatment.
  • TYME-18 has impressive preclinical data showing 11 of 12 mice showing complete responses to their treatment. Now, we wait to see what route Tyme will pick for TYME-18's IND.
  • I discuss my leading near-term downside risk and why I am looking to employ a bamboo approach to TYME.

For further details see:

TYME Technologies: My Bamboo Speculation In A Potential Leader In Cancer Metabolism-Based Therapies.
Stock Information
Company Name: Tyme Technologies Inc.
Stock Symbol: TYME
Market: NASDAQ
Website: tymeinc.com
Menu
TYME TYME Quote TYME Short TYME News TYME Articles TYME Message Board
Get TYME Alerts

News, Short Squeeze, Breakout and More Instantly...